Home Page
Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Donate Now
Access Resources

MJFF Publications
3981 - 3990 of 9145 Results
Title
Year
  • Year
  • 2016
  • 2018
  • 2012
  • 2011
  • 2009
  • 2011
  • 2018
  • 2017
  • 2011
  • 2017
  • Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
    2016
    Summary Details
    OPEN
    Title: Different PD-MCI criteria and risk of dementia in Parkinson’s disease: 4-year longitudinal study
    Author(s): Kyla-Louise Wood, Daniel J. Myall, Leslie Livingston, Tracy R. Melzer, Toni L. Pitcher, Michael R MacAskill, Gert J. Geurtsen, Tim Anderson, John C. Dalrymple‐Alford
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Vol: 2
    Issue #: 1
    Start Page: 15027
    End Page: 15027
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/npjparkd.2015.27
    Best OA location URL: https://www.nature.com/articles/npjparkd201527.pdf
    Citation Count: 83
  • Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia
    2018
    Summary Details
    OPEN
    Title: Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular Dystonia
    Author(s): Laura Scorr, Michael R. Silver, John Hanfelt, Elaine Sperin, Alan Freeman, Hyder A. Jinnah, Stewart A. Factor
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Vol: 15
    Issue #: 2
    Start Page: 452
    End Page: 458
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s13311-018-0620-9
    Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-018-0620-9.pdf
    Citation Count: 12
  • Increased risk of parkinsonism associated with welding exposure
    2012
    Summary Details
    RESTRICTED
    Title: Increased risk of parkinsonism associated with welding exposure
    Author(s): Brad A. Racette, Susan R. Criswell, Jessica I. Lundin, Angela Hobson, Noah Seixas, Paul T. Kotzbauer, Bradley Evanoff, Joel S. Perlmutter, Jing Zhang, Lianne Sheppard, Harvey Checkoway
    Journal Name: NeuroToxicology
    Publisher: Elsevier BV
    Vol: 33
    Issue #: 5
    Start Page: 1356
    End Page: 1361
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuro.2012.08.011
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3651999
    Citation Count: 162
  • β-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease
    2011
    Summary Details
    OPEN
    Title: β-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease
    Author(s): Jason R. Richardson, Ananya Roy, Stuart L. Shalat, Brian Buckley, Bożena Winnik, Marla Gearing, Allan I. Levey, Stewart A. Factor, Padraig O’Suilleabhain, Dwight C. German
    Journal Name: NeuroToxicology
    Publisher: Elsevier BV
    Vol: 32
    Issue #: 5
    Start Page: 640
    End Page: 645
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuro.2011.04.002
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3176949
    Citation Count: 56
  • Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease
    2009
    Summary Details
    RESTRICTED
    Title: Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease
    Author(s): Wei Zhang, Kester A. Phillips, Albert R. Wielgus, Jie Liu, Alberto Albertini, Fabio A. Zucca, Rudolph Faust, Steven Y. Qian, David S. Miller, Colin F. Chignell, Belinda Wilson, Vernice Jackson‐Lewis, Serge Przedborski, Danielle Joset, John D. Loike, Jau‐Shyong Hong, David Sulzer, Luigi Zecca
    Journal Name: Neurotoxicity Research
    Publisher: Springer Science and Business Media LLC
    Vol: 19
    Issue #: 1
    Start Page: 63
    End Page: 72
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12640-009-9140-z
    Citation Count: 257
  • Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
    2011
    Summary Details
    OPEN
    Title: Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
    Author(s): Xianming Deng, Nicolas Dzamko, Alan R. Prescott, Paul Davies, Qingsong Liu, Qingkai Yang, Jiing‐Dwan Lee, Matthew P. Patricelli, Tyzoon Nomanbhoy, Dario R. Alessi, Nathanael S. Gray
    Journal Name: Nature Chemical Biology
    Publisher: Springer Science and Business Media LLC
    Vol: 7
    Issue #: 4
    Start Page: 203
    End Page: 205
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nchembio.538
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3287420
    Citation Count: 431
  • Cognitive training for freezing of gait in Parkinson’s disease: a randomized controlled trial
    2018
    Summary Details
    OPEN
    Title: Cognitive training for freezing of gait in Parkinson’s disease: a randomized controlled trial
    Author(s): Courtney C. Walton, Loren Mowszowski, Moran Gilat, Julie M. Hall, Claire O’Callaghan, Alana J. Muller, Matthew Georgiades, Jennifer Y. Y. Szeto, Kaylena A. Ehgoetz Martens, James M. Shine, Sharon L. Naismith, Simon J.G. Lewis
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Vol: 4
    Issue #: 1
    Start Page: 15
    End Page: 15
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-018-0052-6
    Best OA location URL: https://www.nature.com/articles/s41531-018-0052-6.pdf
    Citation Count: 93
  • Integrated molecular landscape of Parkinson’s disease
    2017
    Summary Details
    OPEN
    Title: Integrated molecular landscape of Parkinson’s disease
    Author(s): Cornelius J. H. M. Klemann, Gerard J.M. Martens, Manu Sharma, Marijn Bart Martens, Ole Isacson, Thomas Gasser, Jasper E. Visser, Geert Poelmans
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Vol: 3
    Issue #: 1
    Start Page: 14
    End Page: 14
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0015-3
    Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2020-01126%22
    Citation Count: 126
  • Expert Testimony at the Food and Drug Administration: Who Wants the Truth?
    2011
    Summary Details
    RESTRICTED
    Title: Expert Testimony at the Food and Drug Administration: Who Wants the Truth?
    Author(s): Joel S. Perlmutter
    Journal Name: Narrative Inquiry in Bioethics
    Publisher: Project MUSE
    Vol: 1
    Issue #: 2
    Start Page: 78
    End Page: 82
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1353/nib.2011.0046
    Citation Count: 0
  • Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
    2017
    Summary Details
    OPEN
    Title: Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
    Author(s): Reinhard Stöger, Paula J. Scaife, Freya Shephard, Lisa Chakrabarti
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Vol: 3
    Issue #: 1
    Start Page: 6
    End Page: 6
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-017-0007-3
    Best OA location URL: https://www.nature.com/articles/s41531-017-0007-3.pdf
    Citation Count: 36

We are charting the path to a future free from Parkinson’s. Your support will get us there.

Give Today About Our Campaign
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.